Polar Capital Holdings Plc (POLR) [Rocket]

Date Filed	Type	Description
07/28/2023	SC 13G	Polar Capital Holdings Plc reports a 5% stake in AEGLEA BIOTHERAPEUTICS, INC.
07/13/2023	SC 13G/A	Polar Capital Holdings Plc reports a 8.1% stake in Nanostring Technologies, Inc.
02/14/2023	SC 13G/A	Polar Capital Holdings Plc reports a 0% stake in Summit Therapeutics Inc.
02/14/2023	SC 13G	Polar Capital Holdings Plc reports a 5.9% stake in Revance Therapeutics, Inc.
02/14/2023	SC 13G/A	Polar Capital Holdings Plc reports a 0% stake in Quotient Limited
02/14/2023	SC 13G	Polar Capital Holdings Plc reports a 8.1% stake in Nanostring Technologies, Inc.
02/14/2022	SC 13G/A	Polar Capital Holdings Plc reports a 2.4% stake in Bellus Health Inc.
02/14/2022	SC 13G/A	Polar Capital Holdings Plc reports a 6.4% stake in Summit Therapeutics Inc.
02/14/2022	SC 13G/A	Polar Capital Holdings Plc reports a 9% stake in Quotient Limited
02/14/2022	SC 13G/A	Polar Capital Holdings Plc reports a 0% stake in Oxford Immunotec Global PLC
02/14/2022	SC 13G	Polar Capital Holdings Plc reports a 5.6% stake in Infinity Pharmaceuticals, Inc.
02/14/2022	SC 13G/A	Polar Capital Holdings Plc reports a 4.8% stake in AVADEL PHARMACEUTICALS PLC
02/16/2021	SC 13G	Polar Capital Holdings Plc reports a 5.2% stake in AVADEL PHARMACEUTICALS PLC
02/16/2021	SC 13G/A	Polar Capital Holdings Plc reports a 4.5% stake in Bellus Health Inc.
02/16/2021	SC 13G/A	Polar Capital Holdings Plc reports a 9.9% stake in Oxford Immunotec Global PLC
02/16/2021	SC 13G/A	Polar Capital Holdings Plc reports a 9.2% stake in Quotient Limited
02/16/2021	SC 13G	Polar Capital Holdings Plc reports a 7% stake in Summit Therapeutics Inc.